Company registration number 08762404 (England and Wales)
BESPOKE HEALTHCARE PRODUCTS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 DECEMBER 2020
PAGES FOR FILING WITH REGISTRAR
BESPOKE HEALTHCARE PRODUCTS LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
BESPOKE HEALTHCARE PRODUCTS LIMITED
BALANCE SHEET
AS AT
30 DECEMBER 2020
30 December 2020
- 1 -
2020
2019
Notes
£
£
£
£
Fixed assets
Intangible assets
3
103
202
Tangible assets
4
215,447
226,457
215,550
226,659
Current assets
Stocks
5,000
7,700
Debtors
5
22,673
83,750
Cash at bank and in hand
6,347
3,014
34,020
94,464
Creditors: amounts falling due within one year
6
(85,684)
(62,449)
Net current (liabilities)/assets
(51,664)
32,015
Total assets less current liabilities
163,886
258,674
Creditors: amounts falling due after more than one year
7
(106,500)
(150,958)
Provisions for liabilities
(4,496)
(5,458)
Net assets
52,890
102,258
Capital and reserves
Called up share capital
8
100
100
Profit and loss reserves
52,790
102,158
Total equity
52,890
102,258
The director of the company has elected not to include a copy of the profit and loss account within the financial statements.
true
For the financial period ended 30 December 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
T
he members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476
.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
BESPOKE HEALTHCARE PRODUCTS LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 DECEMBER 2020
30 December 2020
- 2 -
The financial statements were approved and signed by the director and authorised for issue on 21 July 2022
N Akram
Director
Company Registration No. 08762404
BESPOKE HEALTHCARE PRODUCTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 DECEMBER 2020
- 3 -
1
Accounting policies
Company information
Bespoke Healthcare Products Limited is a
private
company
limited by shares
incorporated in
England and Wales
.
The registered office is
201 Bristol Avenue, Blackpool, Lancashire, FY2 0JF.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in
sterling
, which is the functional currency of the company.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
The company finances its operations by means of
true
bank
borrowing fa
cilit
ies
. The director is not aware of any reason why the
facilities
will not be maintained at
their
current level. As a result the director has continued to adopt the going concern basis in preparing the financial statements.
Whilst the director has adopted the going concern basis set out above, the impact of the worldwide Coronavirus pandemic, Covid-19, on all businesses represents an uncertainty and the true impact of this pandemic will only become apparent over time.
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business
, and
is shown net of VAT and other sales related taxes
.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer
(usually on dispatch of the goods)
, the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
1.4
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
Intangible assets are being amortised evenly over their estimated useful life of five years.
1.5
Tangible fixed assets
Tangible fixed assets
are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:
Freehold land and buildings
over 99 years
Fixtures and fittings
25% on cost
Computers
25% on cost
Motor vehicles
25% on cost
BESPOKE HEALTHCARE PRODUCTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2020
1
Accounting policies
(Continued)
- 4 -
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and
is credited or charged to profit or loss
.
1.6
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell
after making due allowance for obsolete and slow moving items.
Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
1.7
Cash and cash equivalents
Cash and cash equivalents
are basic financial assets
and
include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.8
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset
, with
the net amounts presented in the financial statements
,
when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
1.9
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.10
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the
period
. Taxable profit differs from net profit as reported in the
profit and loss account
because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The
company’s
liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
BESPOKE HEALTHCARE PRODUCTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2020
1
Accounting policies
(Continued)
- 5 -
1.11
Government grants
Government grants are recognised at the fair value of the asset receive
d
or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.
A grant that specifies performance conditions is recognised in income when the performance conditions are met
. Where a
grant does not specify performance conditions
it
is recognised in income when the proceeds are received or receivable
. A grant received before the recognition criteria are satisfied is recognised as a liability.
2
Employees
The average monthly number of persons (including directors) employed by the company during the period was:
2020
2019
Number
Number
Total
2
2
3
Intangible fixed assets
Other
£
Cost
At 1 January 2020 and 30 December 2020
499
Amortisation and impairment
At 1 January 2020
297
Amortisation charged for the period
99
At 30 December 2020
396
Carrying amount
At 30 December 2020
103
At 31 December 2019
202
BESPOKE HEALTHCARE PRODUCTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2020
- 6 -
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 January 2020
201,993
75,960
277,953
Additions
4,184
4,184
At 30 December 2020
201,993
80,144
282,137
Depreciation and impairment
At 1 January 2020
8,170
43,326
51,496
Depreciation charged in the period
2,040
13,154
15,194
At 30 December 2020
10,210
56,480
66,690
Carrying amount
At 30 December 2020
191,783
23,664
215,447
At 31 December 2019
193,823
32,634
226,457
5
Debtors
2020
2019
Amounts falling due within one year:
£
£
Trade debtors
10,217
Corporation tax recoverable
740
Other debtors
21,933
73,533
22,673
83,750
BESPOKE HEALTHCARE PRODUCTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2020
- 7 -
6
Creditors: amounts falling due within one year
2020
2019
£
£
Bank loans and overdrafts
27,918
12,208
Net obligations due under hire purchase contracts
5,872
6,249
Trade creditors
24,725
14,247
Corporation tax
9,825
23,247
Other taxation and social security
4,040
597
Other creditors
10,304
2,351
Accruals and deferred income
3,000
3,550
85,684
62,449
Net obligations due under hire purchase contracts are secured on the assets fin
anced.
Included within bank borrowings is an amount of
£
52,059
that is
secured by a fixed and floating charge over the assets of the company.
7
Creditors: amounts falling due after more than one year
2020
2019
£
£
Bank loans and overdrafts
92,059
132,732
Net obligations due under hire purchase contracts
14,441
18,226
106,500
150,958
Amounts included above which fall due after five years are as follows:
Payable by instalments
67,000
80,535
BESPOKE HEALTHCARE PRODUCTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 DECEMBER 2020
- 8 -
8
Called up share capital
2020
2019
2020
2019
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100
9
Directors' transactions
During the period, the company operated a loan account with the director. At the balance sheet date, an amount of £
21,932
was owed to the company (201
9
- £
71,220
).
2020-12-30
2020-01-01
false
21 July 2022
CCH Software
CCH Accounts Production 2022.100
No description of principal activity
N Akram
08762404
2020-01-01
2020-12-30
08762404
2020-12-30
08762404
2019-12-31
08762404
core:IntangibleAssetsOtherThanGoodwill
2020-12-30
08762404
core:IntangibleAssetsOtherThanGoodwill
2019-12-31
08762404
core:LandBuildings
2020-12-30
08762404
core:OtherPropertyPlantEquipment
2020-12-30
08762404
core:LandBuildings
2019-12-31
08762404
core:OtherPropertyPlantEquipment
2019-12-31
08762404
core:CurrentFinancialInstruments
core:WithinOneYear
2020-12-30
08762404
core:CurrentFinancialInstruments
core:WithinOneYear
2019-12-31
08762404
core:Non-currentFinancialInstruments
core:AfterOneYear
2020-12-30
08762404
core:Non-currentFinancialInstruments
core:AfterOneYear
2019-12-31
08762404
core:CurrentFinancialInstruments
2020-12-30
08762404
core:CurrentFinancialInstruments
2019-12-31
08762404
core:Non-currentFinancialInstruments
2020-12-30
08762404
core:Non-currentFinancialInstruments
2019-12-31
08762404
core:ShareCapital
2020-12-30
08762404
core:ShareCapital
2019-12-31
08762404
core:RetainedEarningsAccumulatedLosses
2020-12-30
08762404
core:RetainedEarningsAccumulatedLosses
2019-12-31
08762404
bus:Director1
2020-01-01
2020-12-30
08762404
core:LandBuildings
core:OwnedOrFreeholdAssets
2020-01-01
2020-12-30
08762404
core:FurnitureFittings
2020-01-01
2020-12-30
08762404
core:ComputerEquipment
2020-01-01
2020-12-30
08762404
core:MotorVehicles
2020-01-01
2020-12-30
08762404
2019-01-01
2019-12-31
08762404
core:IntangibleAssetsOtherThanGoodwill
2019-12-31
08762404
core:IntangibleAssetsOtherThanGoodwill
2020-01-01
2020-12-30
08762404
core:LandBuildings
2019-12-31
08762404
core:OtherPropertyPlantEquipment
2019-12-31
08762404
2019-12-31
08762404
core:LandBuildings
2020-01-01
2020-12-30
08762404
core:OtherPropertyPlantEquipment
2020-01-01
2020-12-30
08762404
core:WithinOneYear
2020-12-30
08762404
core:WithinOneYear
2019-12-31
08762404
bus:PrivateLimitedCompanyLtd
2020-01-01
2020-12-30
08762404
bus:SmallCompaniesRegimeForAccounts
2020-01-01
2020-12-30
08762404
bus:FRS102
2020-01-01
2020-12-30
08762404
bus:AuditExemptWithAccountantsReport
2020-01-01
2020-12-30
08762404
bus:FullAccounts
2020-01-01
2020-12-30
xbrli:pure
xbrli:shares
iso4217:GBP